A detailed history of Ayrshire Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ayrshire Capital Management LLC holds 44,524 shares of ABT stock, worth $5.07 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
44,524
Previous 44,335 0.43%
Holding current value
$5.07 Million
Previous $5.04 Million 8.2%
% of portfolio
2.46%
Previous 2.86%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$100.73 - $112.44 $19,037 - $21,251
189 Added 0.43%
44,524 $4.63 Million
Q1 2024

Apr 17, 2024

BUY
$109.52 - $120.96 $643,320 - $710,519
5,874 Added 15.27%
44,335 $5.04 Million
Q4 2023

Jan 09, 2024

SELL
$90.19 - $110.4 $3,427 - $4,195
-38 Reduced 0.1%
38,461 $4.23 Million
Q3 2023

Oct 12, 2023

SELL
$95.53 - $114.62 $852,223 - $1.02 Million
-8,921 Reduced 18.81%
38,499 $3.73 Million
Q2 2023

Jul 14, 2023

SELL
$100.78 - $112.29 $20,156 - $22,458
-200 Reduced 0.42%
47,420 $5.17 Million
Q1 2023

Apr 13, 2023

BUY
$96.86 - $114.01 $11,913 - $14,023
123 Added 0.26%
47,620 $4.82 Million
Q4 2022

Jan 11, 2023

BUY
$95.06 - $111.52 $22,148 - $25,984
233 Added 0.49%
47,497 $0
Q3 2022

Oct 11, 2022

BUY
$96.76 - $112.03 $144,269 - $167,036
1,491 Added 3.26%
47,264 $4.57 Million
Q2 2022

Jul 08, 2022

SELL
$102.07 - $123.37 $137,284 - $165,932
-1,345 Reduced 2.85%
45,773 $4.97 Million
Q1 2022

Apr 19, 2022

BUY
$114.02 - $139.04 $225,417 - $274,882
1,977 Added 4.38%
47,118 $5.58 Million
Q4 2021

Jan 12, 2022

BUY
$115.53 - $141.46 $62,732 - $76,812
543 Added 1.22%
45,141 $6.35 Million
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $17,149 - $18,971
-147 Reduced 0.33%
44,598 $5.27 Million
Q2 2021

Aug 10, 2021

BUY
$105.79 - $124.53 $124,303 - $146,322
1,175 Added 2.7%
44,745 $5.19 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $15,564 - $18,336
143 Added 0.33%
43,570 $5.22 Million
Q4 2020

Jan 21, 2021

BUY
$105.0 - $114.42 $210,840 - $229,755
2,008 Added 4.85%
43,427 $4.76 Million
Q3 2020

Oct 20, 2020

BUY
$91.64 - $111.29 $73,495 - $89,254
802 Added 1.97%
41,419 $4.51 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $165,161 - $211,386
2,157 Added 5.61%
40,617 $3.71 Million
Q1 2020

Apr 17, 2020

BUY
$62.82 - $91.86 $69,039 - $100,954
1,099 Added 2.94%
38,460 $3.04 Million
Q4 2019

Jan 30, 2020

BUY
$78.51 - $87.4 $2.93 Million - $3.27 Million
37,361 New
37,361 $3.25 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ayrshire Capital Management LLC Portfolio

Follow Ayrshire Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrshire Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrshire Capital Management LLC with notifications on news.